[EN] HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS<br/>[FR] DERIVES DE PYRIDINE HETEROSUBSTITUES, EN TANT QU'INHIBITEURS DE PDE 4
申请人:MERCK FROSST CANADA INC
公开号:WO2000069824A1
公开(公告)日:2000-11-23
The invention encompasses the novel compound of Formula (I) useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). The invention also encompasses pharmaceutical compositions and methods for treatment.